ArticlePloS one2025
Synergistic and individual actions of nanoemulsified vegetable oil and betaine as natural growth promoters on broiler performance, serum proteins, lipid profile, and safety enzymes.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluates the effects of betaine (Betafin®; BET) and soybean oil nano-emulsion (Magic Oil®, NEPO) and their combination (NEPO+BET) as natural drinking water supplements on broiler chickens during the finisher phase. A trial was conducted using 320 Ross 308 broilers divided into four groups: control (no NEPO, no BET), NEPO only (1 mL/L water), BET only (1 g/L water), and their combination (both together; NEPO+BET). Growth performance parameters were assessed at 21, 28, and 35 days, with serum biochemical analyses performed at day 35. Results indicated that NEPO and BET individually improved growth rate and feed efficiency without increasing feed intake and improved metabolic indices, such as reducing low-density lipoprotein cholesterol, risk of hypercholesterolemia ratio, creatinine, and alkaline phosphatase compared with control, while the combined treatment (NEPO+BET) yielded the most pronounced effects. Thus, NEPO+BET treatment significantly gave the best FCR, albumin, globulin, triglycerides, and very-low-density lipoprotein values (p < 0.05) compared to other groups, suggesting synergism in enhancing feed efficiency, enhancing protein metabolism and lipid homeostasis. BET independently lowered serum glucose. Liver and kidney function markers remained within normal ranges, indicating the safety of these additives. These findings support the use of NEPO+BET as effective growth promoters in poultry nutrition through improved nutrient utilization. Future studies should explore the molecular mechanisms involved and the long-term implications of their use in commercial poultry production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.